Search Count: 20
 |
Hiv-1 Wild Type Protease With Grl-052-16A, A Tricyclic Cyclohexane Fused Tetrahydrofuranofuran (Chf-Thf) Derivative As The P2 Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.25 Å Release Date: 2020-05-13 Classification: ANTIVIRAL PROTEIN |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2020-05-13
 |
Hiv-1 Wild Type Protease With Grl-019-17A, A Tricyclic Cyclohexane Fused Tetrahydrofuranofuran (Chf-Thf) Derivative As The P2 Ligand And A Aminobenzothiazole(Abt)-Based P2'-Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.30 Å Release Date: 2020-05-13 Classification: ANTIVIRAL PROTEIN |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2020-05-13
 |
Hiv-1 Wild Type Protease With Grl-02815A, A Thiochroman Heterocycle With (S)-Boc-Amine Functionality As The P2 Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.20 Å Release Date: 2018-10-31 Classification: HYDROLASE, ANTIVIRAL PROTEIN |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-10-31
 |
Hiv-1 Wild Type Protease With Grl-04315A, A Tetrahydronaphthalene Carboxamide With (R)-Boc-Amine And (S)-Hydroxyl Functionalities As The P2 Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.14 Å Release Date: 2018-10-31 Classification: HYDROLASE, ANTIVIRAL PROTEIN |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-10-31
 |
Hiv-1 Wild Type Protease With Grl-03314A, 6-5-5-Ring Fused Umbrella-Like Tetrahydropyranofuran As The P2-Ligand, A Cyclopropylaminobenzothiazole As The P2'-Ligand And 3,5-Difluorophenylmethyl As The P1-Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.13 Å Release Date: 2018-05-30 Classification: HYDROLASE/HYDROLASE inhibitor Ligands: GR8, NA, CL, GOL, ACT |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
Ligands: GR8, NA, CL, GOL, ACT
 |
Hiv-1 Wild Type Protease With Grl-03214A, 6-5-5-Ring Fused Umbrella-Like Tetrahydropyranofuran As The P2-Ligand, A Cyclopropylaminobenzothiazole As The P2'-Ligand And 3,5-Difluorophenylmethyl As The P1-Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.25 Å Release Date: 2018-05-30 Classification: HYDROLASE/HYDROLASE inhibitor |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-05-30
 |
Crystal Structure Of Wild-Type Hiv-1 Protease With A Novel Hiv-1 Inhibitor Grl-14213A Of 6-5-5-Ring Fused Crown-Like Tetrahydropyranofuran As The P2-Ligand, A Cyclopropylaminobenzothiazole As The P2'-Ligand And 3,5-Difluorophenylmethyl As The P1-Ligand
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.67 Å Release Date: 2018-02-28 Classification: HYDROLASE/HYDROLASE inhibitor |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2018-02-28
 |
X-Ray Crystal Structure Of Wild Type Hiv-1 Protease In Complex With Grl-121
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.80 Å Release Date: 2017-10-18 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 7O7 |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2017-10-18
Ligands: 7O7
 |
X-Ray Crystal Structure Of Wild Type Hiv-1 Protease In Complex With Grl-142
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.01 Å Release Date: 2017-10-18 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: 7OA |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2017-10-18
Ligands: 7OA
 |
Hiv-1 Wild Type Protease With Grl-100-13A (A Crown-Like Oxotricyclic Core As The P2-Ligand With The Sulfonamide Isostere As The P2' Group)
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.53 Å Release Date: 2017-05-03 Classification: hydrolase/hydrolase inhibitor |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2017-05-03
 |
Hiv-1 Wild Type Protease With Grl-097-13A (A Adamantane P1-Ligand With Bis-Thf In P2 And Isobutylamine In P1')
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.49 Å Release Date: 2016-09-21 Classification: HYDROLASE/HYDROLASE inhibitor |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2016-09-21
 |
Hiv-1 Wild Type Protease With Grl-007-14A (A Adamantane P1-Ligand With Bis-Thf In P2 And Benzylamine In P1')
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2016-09-21 Classification: hydrolase/hydrolase inhibitor Ligands: CL, 6KQ |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2016-09-21
Ligands: CL, 6KQ
 |
Hiv-1 Wild Type Protease With Grl-031-14A (A Adamantane P1-Ligand With Tetrahydropyrano-Tetrahydrofuran In P2 And Isobutylamine In P1')
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.16 Å Release Date: 2016-09-21 Classification: hydrolase/hydrolase inhibitor |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2016-09-21
 |
2.1 A X-Ray Structure Of Fipv-3Clpro Bound To Covalent Inhibitor
Organism: Feline coronavirus (strain fipv wsu-79/1146), Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.06 Å Release Date: 2015-10-14 Classification: Hydrolase/Hydrolase Inhibitor Ligands: DMS |
Organism: Feline coronavirus (strain fipv wsu-79/1146), Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2015-10-14
Ligands: DMS
 |
Hiv-1 Wild Type Protease With Grl-011-11A (A Methylamine Bis-Tetrahydrofuran P2-Ligand, Sulfonamide Isostere Derivate)
Organism: Human immunodeficiency virus type 1 bh10
Method: X-RAY DIFFRACTION Resolution:1.34 Å Release Date: 2015-09-09 Classification: HYDROLASE/HYDROLASE Inhibitor |
Organism: Human immunodeficiency virus type 1 bh10
Method: X-RAY DIFFRACTION
Release Date: 2015-09-09
 |
Hiv-1 Wild Type Protease With Grl-047-11A (A Methylamine Bis-Tetrahydrofuran P2-Ligand, 4-Amino Sulfonamide Derivative)
Organism: Human immunodeficiency virus type 1 bh10
Method: X-RAY DIFFRACTION Resolution:1.29 Å Release Date: 2015-09-09 Classification: HYDROLASE/HYDROLASE Inhibitor Ligands: 4UX, NA, CL, ACT |
Organism: Human immunodeficiency virus type 1 bh10
Method: X-RAY DIFFRACTION
Release Date: 2015-09-09
Ligands: 4UX, NA, CL, ACT
 |
Hiv-1 Wild Type Protease With Grl-096-13A (A Boc-Derivative P2-Ligand, 3,-5-Dimethylbiphenyl P1-Ligand)
Organism: Human immunodeficiency virus type 1 bh10
Method: X-RAY DIFFRACTION Resolution:1.53 Å Release Date: 2015-07-15 Classification: HYDROLASE/HYDROLASE Inhibitor |
Organism: Human immunodeficiency virus type 1 bh10
Method: X-RAY DIFFRACTION
Release Date: 2015-07-15
 |
X-Ray Structure Of Mers-Cov Nsp5 Protease Bound With A Designed Inhibitor
Organism: Middle east respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:1.62 Å Release Date: 2015-06-17 Classification: Hydrolase/hydrolase Inhibitor |
Organism: Middle east respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2015-06-17
 |
X-Ray Structure Of Mers-Cov Nsp5 Protease Bound With A Non-Covalent Inhibitor
Organism: Middle east respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2015-06-17 Classification: HYDROLASE/HYDROLASE INHIBITOR Ligands: R30, ACT |
Organism: Middle east respiratory syndrome coronavirus
Method: X-RAY DIFFRACTION
Release Date: 2015-06-17
Ligands: R30, ACT
 |
Crystal Structure Of Wild-Type Hiv-1 Protease With Novel Tricyclic P2-Ligands Grl-0739A
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:1.29 Å Release Date: 2013-09-04 Classification: Hydrolase/Hydrolase Inhibitor Ligands: G79, CL, ACT, NA, GOL |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2013-09-04
Ligands: G79, CL, ACT, NA, GOL